Refining our understanding of these expression patterns in human will be critical in particular as the KHK protein product has already been identified as a promising target in the treatment of non-alcoholic steato-hepatitis (NASH)41. This evidence concerns the gene KHK and metabolic dysfunction-associated steatohepatitis.